OncoTherapy Science, Inc. (4564.T)
JPY 26.0
(-3.7%)
JPY 26.0
(-3.7%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 73.99 Million JPY | -25.72% |
| 2022 | 99.61 Million JPY | -56.88% |
| 2021 | 231.04 Million JPY | 462.6% |
| 2020 | 41.06 Million JPY | 64.74% |
| 2019 | 24.92 Million JPY | -1.59% |
| 2018 | 25.33 Million JPY | 74.01% |
| 2017 | 14.55 Million JPY | 11.9% |
| 2016 | 13.01 Million JPY | -17.54% |
| 2015 | 15.77 Million JPY | -28.29% |
| 2014 | 22 Million JPY | -16.35% |
| 2013 | 26.3 Million JPY | 1.01% |
| 2012 | 26.03 Million JPY | 10.66% |
| 2011 | 23.53 Million JPY | -6.51% |
| 2010 | 25.16 Million JPY | -27.08% |
| 2009 | 34.51 Million JPY | -29.62% |
| 2008 | 49.04 Million JPY | 4.11% |
| 2007 | 47.1 Million JPY | 83.71% |
| 2006 | 25.64 Million JPY | 224.49% |
| 2005 | 7.9 Million JPY | -66.65% |
| 2004 | 23.69 Million JPY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 128 Million JPY | 72.98% |
| 2023 Q3 | 132.94 Million JPY | 30.06% |
| 2023 FY | 73.99 Million JPY | -25.72% |
| 2023 Q4 | 73.99 Million JPY | -44.34% |
| 2023 Q2 | 102.22 Million JPY | -34.42% |
| 2023 Q1 | 155.88 Million JPY | 56.48% |
| 2022 Q1 | 137.95 Million JPY | -40.29% |
| 2022 Q2 | 128.17 Million JPY | -7.09% |
| 2022 Q3 | 237.2 Million JPY | 85.06% |
| 2022 FY | 99.61 Million JPY | -56.88% |
| 2022 Q4 | 99.61 Million JPY | -58.0% |
| 2021 Q3 | 282.87 Million JPY | 329.29% |
| 2021 Q4 | 231.04 Million JPY | -18.32% |
| 2021 Q2 | 65.89 Million JPY | -13.56% |
| 2021 FY | 231.04 Million JPY | 462.6% |
| 2021 Q1 | 76.22 Million JPY | 85.62% |
| 2020 Q4 | 41.06 Million JPY | 97.59% |
| 2020 FY | 41.06 Million JPY | 64.74% |
| 2020 Q1 | 26.04 Million JPY | 4.49% |
| 2020 Q3 | 20.78 Million JPY | -16.09% |
| 2020 Q2 | 24.76 Million JPY | -4.91% |
| 2019 Q3 | 23.78 Million JPY | -25.79% |
| 2019 Q2 | 32.04 Million JPY | -16.4% |
| 2019 Q4 | 24.92 Million JPY | 4.81% |
| 2019 FY | 24.92 Million JPY | -1.59% |
| 2019 Q1 | 38.33 Million JPY | 51.34% |
| 2018 Q1 | 16.45 Million JPY | 13.02% |
| 2018 Q4 | 25.33 Million JPY | -36.23% |
| 2018 Q3 | 39.72 Million JPY | 104.75% |
| 2018 FY | 25.33 Million JPY | 74.01% |
| 2018 Q2 | 19.4 Million JPY | 17.91% |
| 2017 Q2 | 12.97 Million JPY | -1.99% |
| 2017 FY | 14.55 Million JPY | 11.9% |
| 2017 Q1 | 13.24 Million JPY | 1.79% |
| 2017 Q3 | 12.13 Million JPY | -6.47% |
| 2017 Q4 | 14.55 Million JPY | 19.93% |
| 2016 Q4 | 13.01 Million JPY | -11.15% |
| 2016 FY | 13.01 Million JPY | -17.54% |
| 2016 Q3 | 14.64 Million JPY | -15.23% |
| 2016 Q2 | 17.27 Million JPY | 6.17% |
| 2016 Q1 | 16.26 Million JPY | 3.11% |
| 2015 Q4 | 15.77 Million JPY | -0.47% |
| 2015 Q2 | 22.12 Million JPY | -7.94% |
| 2015 Q1 | 24.02 Million JPY | 9.22% |
| 2015 FY | 15.77 Million JPY | -28.29% |
| 2015 Q3 | 15.85 Million JPY | -28.34% |
| 2014 Q4 | 22 Million JPY | -8.57% |
| 2014 FY | 22 Million JPY | -16.35% |
| 2014 Q3 | 24.06 Million JPY | 13.87% |
| 2014 Q2 | 21.13 Million JPY | -5.79% |
| 2014 Q1 | 22.42 Million JPY | -14.72% |
| 2013 Q3 | 25.69 Million JPY | 12.28% |
| 2013 Q4 | 26.3 Million JPY | 2.34% |
| 2013 Q2 | 22.88 Million JPY | -20.94% |
| 2013 FY | 26.3 Million JPY | 1.01% |
| 2013 Q1 | 28.95 Million JPY | 11.19% |
| 2012 FY | 26.03 Million JPY | 10.66% |
| 2012 Q1 | 24.42 Million JPY | 3.8% |
| 2012 Q2 | 22.74 Million JPY | -6.87% |
| 2012 Q3 | 20.18 Million JPY | -11.25% |
| 2012 Q4 | 26.03 Million JPY | 28.97% |
| 2011 Q1 | 33 Million JPY | 31.15% |
| 2011 Q2 | 37.21 Million JPY | 12.76% |
| 2011 Q3 | 35.68 Million JPY | -4.12% |
| 2011 Q4 | 23.53 Million JPY | -34.06% |
| 2011 FY | 23.53 Million JPY | -6.51% |
| 2010 Q1 | 29.29 Million JPY | -15.12% |
| 2010 Q3 | 37.14 Million JPY | -17.8% |
| 2010 Q4 | 25.16 Million JPY | -32.25% |
| 2010 FY | 25.16 Million JPY | -27.08% |
| 2010 Q2 | 45.19 Million JPY | 54.26% |
| 2009 Q4 | 34.51 Million JPY | -10.75% |
| 2009 FY | 34.51 Million JPY | -29.62% |
| 2009 Q3 | 38.66 Million JPY | 0.0% |
| 2008 FY | 49.04 Million JPY | 4.11% |
| 2008 Q4 | 49.04 Million JPY | 0.0% |
| 2007 FY | 47.1 Million JPY | 83.71% |
| 2006 FY | 25.64 Million JPY | 224.49% |
| 2005 FY | 7.9 Million JPY | -66.65% |
| 2004 FY | 23.69 Million JPY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 683.01 Million JPY | 89.166% |
| PRISM BioLab Co.,LTD | 17.92 Million JPY | -312.734% |
| GNI Group Ltd. | 2.33 Billion JPY | 96.825% |
| Linical Co., Ltd. | - JPY | -Infinity% |
| Trans Genic Inc. | 2.22 Billion JPY | 96.678% |
| MEDINET Co., Ltd. | 67.48 Million JPY | -9.659% |
| Soiken Holdings Inc. | 1.12 Billion JPY | 93.398% |
| Cytori Cell Research Institute, Inc. | 103.53 Million JPY | 28.527% |
| AnGes, Inc. | 1.61 Billion JPY | 95.42% |
| Nxera Pharma Co., Ltd. | 2.9 Billion JPY | 97.451% |
| Immuno-Biological Laboratories Co., Ltd. | 321.91 Million JPY | 77.013% |
| NanoCarrier Co., Ltd. | 184 Thousand JPY | -40116.848% |
| Carna Biosciences, Inc. | 140.14 Million JPY | 47.196% |
| CanBas Co., Ltd. | 728 Thousand JPY | -10064.698% |
| D. Western Therapeutics Institute, Inc. | 87.86 Million JPY | 15.779% |
| RaQualia Pharma Inc. | 147.93 Million JPY | 49.98% |
| Chiome Bioscience Inc. | 64.1 Million JPY | -15.43% |
| Kidswell Bio Corporation | 875.65 Million JPY | 91.549% |
| PeptiDream Inc. | 2.4 Billion JPY | 96.922% |
| Oncolys BioPharma Inc. | 5.34 Million JPY | -1285.23% |
| Ribomic Inc. | 2.27 Million JPY | -3154.134% |
| SanBio Company Limited | - JPY | -Infinity% |
| Healios K.K. | - JPY | -Infinity% |
| BrightPath Biotherapeutics Co., Ltd. | 1.00 JPY | -7399899900.0% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 36 Million JPY | -105.553% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | 29 Million JPY | -155.169% |
| CellSource Co., Ltd. | 305.92 Million JPY | 75.811% |
| FunPep Company Limited | 25.54 Million JPY | -189.726% |
| Kringle Pharma, Inc. | 364.05 Million JPY | 79.674% |
| Stella Pharma Corporation | 1.11 Billion JPY | 93.371% |
| TMS Co., Ltd. | 50.02 Million JPY | -47.924% |
| Noile-Immune Biotech Inc. | 20.9 Million JPY | -254.045% |
| Cuorips Inc. | 1.04 Million JPY | -6994.823% |
| K Pharma,Inc. | 10.79 Million JPY | -585.557% |
| Takara Bio Inc. | 11.85 Billion JPY | 99.376% |
| ReproCELL Incorporated | 248.14 Million JPY | 70.179% |
| PhoenixBio Co., Ltd. | 450.58 Million JPY | 83.577% |
| StemCell Institute Inc. | 42.26 Million JPY | -75.096% |
| Japan Tissue Engineering Co., Ltd. | 228.56 Million JPY | 67.625% |
| CellSeed Inc. | 46.19 Million JPY | -60.202% |